| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of neurotrophin TRK receptor signaling pathway | 6.13e-07 | 17 | 21 | 3 | GO:0051386 | |
| GeneOntologyBiologicalProcess | neurotrophin TRK receptor signaling pathway | 5.33e-06 | 34 | 21 | 3 | GO:0048011 | |
| GeneOntologyBiologicalProcess | neurotrophin signaling pathway | 1.43e-05 | 47 | 21 | 3 | GO:0038179 | |
| Domain | - | 8.84e-04 | 663 | 22 | 5 | 2.60.40.10 | |
| Domain | Ig-like_fold | 1.17e-03 | 706 | 22 | 5 | IPR013783 | |
| Domain | Ig_I-set | 1.38e-03 | 190 | 22 | 3 | IPR013098 | |
| Domain | I-set | 1.38e-03 | 190 | 22 | 3 | PF07679 | |
| Domain | FN3 | 1.58e-03 | 199 | 22 | 3 | PS50853 | |
| Domain | FN3_dom | 1.82e-03 | 209 | 22 | 3 | IPR003961 | |
| Domain | IG_LIKE | 2.37e-03 | 491 | 22 | 4 | PS50835 | |
| Domain | IGc2 | 2.54e-03 | 235 | 22 | 3 | SM00408 | |
| Domain | Ig_sub2 | 2.54e-03 | 235 | 22 | 3 | IPR003598 | |
| Domain | Ig-like_dom | 2.59e-03 | 503 | 22 | 4 | IPR007110 | |
| Domain | IG | 1.27e-02 | 421 | 22 | 3 | SM00409 | |
| Domain | Ig_sub | 1.27e-02 | 421 | 22 | 3 | IPR003599 | |
| Domain | fn3 | 1.54e-02 | 162 | 22 | 2 | PF00041 | |
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 19846279 | ||
| Pubmed | 1.15e-06 | 3 | 22 | 2 | 18031993 | ||
| Pubmed | Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. | 3.82e-06 | 5 | 22 | 2 | 10227978 | |
| Pubmed | 2.51e-05 | 12 | 22 | 2 | 9754575 | ||
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 5.81e-05 | 18 | 22 | 2 | 25363768 | |
| Pubmed | 5.81e-05 | 18 | 22 | 2 | 23022035 | ||
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 1.23e-04 | 26 | 22 | 2 | 34848499 | |
| Pubmed | β-Cell-Specific Mafk Overexpression Impairs Pancreatic Endocrine Cell Development. | 2.38e-04 | 36 | 22 | 2 | 26901059 | |
| Pubmed | 2.86e-04 | 963 | 22 | 5 | 28671696 | ||
| Pubmed | 3.47e-04 | 219 | 22 | 3 | 29997244 | ||
| Pubmed | 5.16e-04 | 53 | 22 | 2 | 11130978 | ||
| Pubmed | 6.18e-04 | 1139 | 22 | 5 | 36417873 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 3.66e-04 | 294 | 22 | 3 | chr1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p16 | 1.54e-03 | 121 | 22 | 2 | chr2p16 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p21 | 2.39e-02 | 503 | 22 | 2 | chr6p21 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.30e-04 | 161 | 17 | 3 | 593 | |
| GeneFamily | Fibronectin type III domain containing | 9.70e-03 | 160 | 17 | 2 | 555 | |
| GeneFamily | Immunoglobulin like domain containing | 1.39e-02 | 193 | 17 | 2 | 594 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_MAST_CELL_UP | 2.12e-05 | 199 | 22 | 4 | M5397 | |
| CoexpressionAtlas | kidney_e13.5_Podocyte_MafB_k-means-cluster#1_top-relative-expression-ranked_100 | 9.25e-05 | 14 | 22 | 2 | gudmap_kidney_e13.5_Podocyte_MafB_k1_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | 1.10e-04 | 479 | 22 | 5 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500 | |
| ToppCell | VE-matDC-|VE / Condition, Cell_class and T cell subcluster | 1.75e-06 | 181 | 22 | 4 | 6252184ef098b911df50be4fe1b5565849a5b6b8 | |
| ToppCell | VE-matDC|VE / Condition, Cell_class and T cell subcluster | 1.75e-06 | 181 | 22 | 4 | 982fd96ef75bc9ab2c2f4970c01b76ba7a164871 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.65e-05 | 132 | 22 | 3 | c07842a4b514f1e950c8af303f3b6b4275906e6a | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 147 | 22 | 3 | 00619115b9a1ec2b967c2992043b41974ece63c4 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-05 | 159 | 22 | 3 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.59e-05 | 161 | 22 | 3 | bb9cb42882aaa4a1ecf9b480c0e7ac302f2c0d5d | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.37e-05 | 26 | 22 | 2 | e2db677bc0f2011883c8b44058276ecf879d4303 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 169 | 22 | 3 | 7be742160e3e7e6c8f86b037be4e425f4d4cf663 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 169 | 22 | 3 | 4ccf5cfa4fe72d3af056d658460a9ccaa07b01be | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.29e-05 | 174 | 22 | 3 | 75b3a852140fb726025c3c987143d67944afde2d | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.58e-05 | 176 | 22 | 3 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | 8.58e-05 | 176 | 22 | 3 | 72a3bbab0540ae3e3c94b9573cdb9298a024dbc4 | |
| ToppCell | RA-11._Adipocyte|RA / Chamber and Cluster_Paper | 9.17e-05 | 180 | 22 | 3 | d48a3d27357f7d184132a6805950f93080146b59 | |
| ToppCell | Severe-Myeloid-mDC-|Severe / Condition, Lineage, Cell class and cell subclass | 9.32e-05 | 181 | 22 | 3 | 51ded98c76ec35ab1d24ac3ab98280381daa9831 | |
| ToppCell | Severe-Myeloid-mDC|Severe / Condition, Lineage, Cell class and cell subclass | 9.32e-05 | 181 | 22 | 3 | 00f2949b609ac21bd2da6fd8f685739eeb2f48ad | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 9.32e-05 | 181 | 22 | 3 | 94680f8dbdf22d83801abc0819417751d363fb12 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 9.63e-05 | 183 | 22 | 3 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 9.63e-05 | 183 | 22 | 3 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.79e-05 | 184 | 22 | 3 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 1.04e-04 | 188 | 22 | 3 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Dendritic-migDC|GI_small-bowel / Manually curated celltypes from each tissue | 1.08e-04 | 190 | 22 | 3 | e9b2c201d07f0cb87fa60005251c9e1663e246ed | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.08e-04 | 190 | 22 | 3 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.09e-04 | 191 | 22 | 3 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | 18-Distal-Mesenchymal-Cartilage|Distal / Age, Tissue, Lineage and Cell class | 1.13e-04 | 193 | 22 | 3 | 52f3d1bb8d8ca91ba12439d46392f377928ff8f8 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Activated_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.14e-04 | 194 | 22 | 3 | 219056d4ad256cda73208b8c570bbf689219df83 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 195 | 22 | 3 | ecf7d9856a5b507ec17c325c9a772dc5a184bc8e | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.16e-04 | 195 | 22 | 3 | f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff | |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 195 | 22 | 3 | ba494be431916d43c1d480f65bed674c0722c710 | |
| ToppCell | critical-Myeloid-Monocyte-derived_DC|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.16e-04 | 195 | 22 | 3 | 599510a5318eef054c117763c9ff86c90957483a | |
| ToppCell | Control|World / Condition, Lineage and Cell class | 1.18e-04 | 196 | 22 | 3 | 2565f567c5274d1689e11600a2cb9e6770b65f74 | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 1.22e-04 | 198 | 22 | 3 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.22e-04 | 198 | 22 | 3 | 1282db321e27499d310339d6383974614e295a20 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 1.22e-04 | 198 | 22 | 3 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | BAL-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.23e-04 | 199 | 22 | 3 | 0b20ae65b9340d844e271acda9e116d98fc1cc69 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-04 | 199 | 22 | 3 | 9a0e853693e572c63b135f937b2cffd4dd4026fb | |
| ToppCell | Severe_COVID-19-Myeloid-cDC|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.23e-04 | 199 | 22 | 3 | 9132c1929d3445fcca49f76f010ca37adeb70315 | |
| ToppCell | BAL-Severe-Myeloid-cDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-04 | 199 | 22 | 3 | d017848256704ae7237030868b143c3f0842a9c3 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.23e-04 | 199 | 22 | 3 | bb9e7418468b88cdfaa78788d062362794ea8230 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 199 | 22 | 3 | 66b4ff23b2e83fb7e6a37fdafdef315cfa33d327 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.25e-04 | 200 | 22 | 3 | 7c56935446f10d202eafa1f9ee7cb0aae4c2607e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | f7c3a8f5ac156c05ad7335d6d142c154c7d86449 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Alveolar_macrophages|Lung / Manually curated celltypes from each tissue | 1.25e-04 | 200 | 22 | 3 | 3b236900df407bf5a8c44e76d003a7a37d251db6 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-04 | 200 | 22 | 3 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| ToppCell | (53)_Lymphoid_DC|World / shred on Cell_type and subtype | 1.41e-04 | 208 | 22 | 3 | 30212cfacad94a7cc562a69efa73a31259851515 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-03 | 97 | 22 | 2 | f3c3fb260954f594a9ab8e1ac9a01115767cbc7a | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.12e-03 | 101 | 22 | 2 | cf52c93f523c5f25bd45519a1444ce7bd1d8b577 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.28e-03 | 108 | 22 | 2 | 4536cbe1748aee37f0a13648c5679fd592af6322 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Tacr3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.30e-03 | 109 | 22 | 2 | 92ab514fd8d6711f55de9671fc80da22b20ad248 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-03 | 109 | 22 | 2 | 6e90d04c5094c7410d667dae80de3279bddd24bd | |
| ToppCell | normal_Lung-B_lymphocytes-Plasma_cells|normal_Lung / Location, Cell class and cell subclass | 1.40e-03 | 113 | 22 | 2 | 7ec8c1712977d3b8e861d2743ff7bd1797ab35df | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-03 | 118 | 22 | 2 | 3b077ad5c68c01b3fcc93f203cb130bb90705af9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-03 | 118 | 22 | 2 | 3f0a304ef9c9e5ba047fc09f4372590eed624328 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-03 | 118 | 22 | 2 | 08bdf7bc3c9dcbc0f690658fe14e6cc4b9581698 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.60e-03 | 121 | 22 | 2 | 056d0f0f7a4d1b2d38b83647bbe4468b7c959ce6 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.60e-03 | 121 | 22 | 2 | 05c40fd39e6b6275f35aaad835f95a81fcbb0990 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.68e-03 | 124 | 22 | 2 | 298ff8bd8f0459f44ce8a8aea889c6f1cf84ac5f | |
| ToppCell | Control-B_memory-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.68e-03 | 124 | 22 | 2 | 3e987915026f503e8d072a837b6e7a34252e5c63 | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-03 | 125 | 22 | 2 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-03 | 125 | 22 | 2 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.73e-03 | 126 | 22 | 2 | 28fbe63f7bc628b32d8e86bf9e80657e776dd1cc | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Th_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.73e-03 | 126 | 22 | 2 | 3a14d4eb8803827946c36faeeb7ae2913418d421 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nts|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.76e-03 | 127 | 22 | 2 | ace2944328529fa029ee56c7ad3b0f283511d3bb | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-03 | 128 | 22 | 2 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.81e-03 | 129 | 22 | 2 | 64768adf23123b92280fb30eb85147cbee084ae0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.81e-03 | 129 | 22 | 2 | 6bc85761dea1f97c19bb379a99e4daf85d53201e | |
| ToppCell | control-Plasmablast|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.84e-03 | 130 | 22 | 2 | 9fe3c5be8488d341cff38757daf7856c112410d0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.87e-03 | 131 | 22 | 2 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.93e-03 | 133 | 22 | 2 | fc319644868078ea0f88a71d55f5e858c6848b50 | |
| ToppCell | URO-Lymphocyte-T_NK-CD8_Naive|URO / Disease, Lineage and Cell Type | 1.96e-03 | 134 | 22 | 2 | 142b7db0c2b686c8f2704ff7bcd9b44dfcb07403 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.96e-03 | 134 | 22 | 2 | b5466759285b4973850afb2e1be7c1d25f1c7927 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.01e-03 | 136 | 22 | 2 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.10e-03 | 139 | 22 | 2 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.10e-03 | 139 | 22 | 2 | fe1657ef9aeda7c530dc7febcd3dcd0e1d5f8a48 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-03 | 141 | 22 | 2 | cabb5b8c0874813c713508af2ac620ab0d61ab6f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.16e-03 | 141 | 22 | 2 | ad9a25569c142fb68ded34aeba0cd9be8124ce56 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-03 | 141 | 22 | 2 | 3fa3d2a8ebd9c285168ecea6db9cad74d3a3e85a | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.19e-03 | 142 | 22 | 2 | 8b5441d0564e67ab4db58d9082909b5dab430a28 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.19e-03 | 142 | 22 | 2 | efe2418436ad1320b8e8fce38619ac65516ef077 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Malignant_Peripheral_Nerve_Sheath_Tumors|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.22e-03 | 143 | 22 | 2 | d1c8e15a8ae2094de2919e99188f9211b78c5abf | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.22e-03 | 143 | 22 | 2 | 27e06327f96cb72bd111ea6ece6307e5ebb3a146 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 2.22e-03 | 143 | 22 | 2 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-03 | 143 | 22 | 2 | 6df16bf0324661cd9707df69cb39f4b5498d6d49 | |
| ToppCell | severe_COVID-19-B_cell|World / disease group, cell group and cell class (v2) | 2.22e-03 | 143 | 22 | 2 | 28b0e168126a9fe60541dc12bfab385b7a0a2342 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.22e-03 | 143 | 22 | 2 | 4edef95ae2a1ef4fc4b0d4fadf75bfc54b583932 | |
| ToppCell | severe_COVID-19-B_cell|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.25e-03 | 144 | 22 | 2 | c7f696e55e2d959c58ec32640c71ef86ee25203c | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-03 | 146 | 22 | 2 | e03658ead410d003e2b18fe94da086a38560b8e7 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-03 | 146 | 22 | 2 | 9d7122cc640500c7cd93230df06e331c31625bd5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.32e-03 | 146 | 22 | 2 | 10839a4fce2e62955a90592f927a6e0c6a84bbad | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.32e-03 | 146 | 22 | 2 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | droplet-Liver-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-03 | 146 | 22 | 2 | d9df42f8e44018b149a84f07c540cdba74d6374a | |
| ToppCell | droplet-Liver-hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-03 | 146 | 22 | 2 | a9fa64617c7fb7a66de77360c5642c1da91e465c | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 147 | 22 | 2 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 147 | 22 | 2 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 2.38e-03 | 148 | 22 | 2 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.38e-03 | 148 | 22 | 2 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-03 | 148 | 22 | 2 | 763c598826445bf627989220cd7acd71c4f1ea36 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-9|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.38e-03 | 148 | 22 | 2 | 683b2b80ee389469d948aaf6a77632b24f56e989 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-03 | 148 | 22 | 2 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-03 | 148 | 22 | 2 | d3f224128593251b72429a1cd52e82f77df8e386 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-03 | 148 | 22 | 2 | 5c853637f6058f78608ba0e76cda72a548d40710 | |
| Disease | obesity (biomarker_via_orthology) | 3.31e-06 | 147 | 21 | 4 | DOID:9970 (biomarker_via_orthology) | |
| Disease | clinical depression | 7.22e-06 | 6 | 21 | 2 | C2362914 | |
| Disease | Neurodevelopmental Disorders | 3.87e-05 | 93 | 21 | 3 | C1535926 | |
| Disease | treatment-resistant hypertension | 6.21e-05 | 109 | 21 | 3 | EFO_1002006 | |
| Disease | cerebral infarction (is_marker_for) | 8.19e-05 | 19 | 21 | 2 | DOID:3526 (is_marker_for) | |
| Disease | worry measurement | 1.73e-04 | 154 | 21 | 3 | EFO_0009589 | |
| Disease | blood viscosity | 2.22e-04 | 31 | 21 | 2 | EFO_0004301 | |
| Disease | myocardial infarction (is_marker_for) | 2.51e-04 | 33 | 21 | 2 | DOID:5844 (is_marker_for) | |
| Disease | pre-eclampsia (is_marker_for) | 7.78e-04 | 58 | 21 | 2 | DOID:10591 (is_marker_for) | |
| Disease | R-warfarin measurement | 8.45e-04 | 265 | 21 | 3 | EFO_0803324 | |
| Disease | susceptibility to hepatitis B infection measurement | 9.47e-04 | 64 | 21 | 2 | EFO_0008405 | |
| Disease | platelet measurement | 1.39e-03 | 315 | 21 | 3 | EFO_0005036 | |
| Disease | interleukin 10 measurement | 1.40e-03 | 78 | 21 | 2 | EFO_0004750 | |
| Disease | Epilepsy, Cryptogenic | 1.55e-03 | 82 | 21 | 2 | C0086237 | |
| Disease | Awakening Epilepsy | 1.55e-03 | 82 | 21 | 2 | C0751111 | |
| Disease | Aura | 1.55e-03 | 82 | 21 | 2 | C0236018 | |
| Disease | feeling nervous measurement | 1.74e-03 | 87 | 21 | 2 | EFO_0009597 | |
| Disease | obesity (is_marker_for) | 2.33e-03 | 101 | 21 | 2 | DOID:9970 (is_marker_for) | |
| Disease | neutrophil count | 2.43e-03 | 1382 | 21 | 5 | EFO_0004833 | |
| Disease | Epilepsy | 2.71e-03 | 109 | 21 | 2 | C0014544 | |
| Disease | cognitive function measurement | 2.85e-03 | 1434 | 21 | 5 | EFO_0008354 | |
| Disease | interleukin-6 measurement | 2.86e-03 | 112 | 21 | 2 | EFO_0004810 | |
| Disease | Drug Use Disorders | 3.01e-03 | 115 | 21 | 2 | C0013222 | |
| Disease | Drug Dependence | 3.01e-03 | 115 | 21 | 2 | C1510472 | |
| Disease | Drug habituation | 3.01e-03 | 115 | 21 | 2 | C0013170 | |
| Disease | Substance Dependence | 3.01e-03 | 115 | 21 | 2 | C0038580 | |
| Disease | Substance Use Disorders | 3.01e-03 | 115 | 21 | 2 | C0038586 | |
| Disease | Substance-Related Disorders | 3.01e-03 | 115 | 21 | 2 | C0236969 | |
| Disease | Drug abuse | 3.01e-03 | 115 | 21 | 2 | C0013146 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.01e-03 | 115 | 21 | 2 | C0029231 | |
| Disease | Prescription Drug Abuse | 3.01e-03 | 115 | 21 | 2 | C4316881 | |
| Disease | Substance abuse problem | 3.06e-03 | 116 | 21 | 2 | C0740858 | |
| Disease | ocular sarcoidosis | 3.06e-03 | 116 | 21 | 2 | EFO_0010723 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQRLRYGVYVINQHG | 171 | O60909 | |
| GLRAYIRRQINHIFY | 271 | Q14738 | |
| NGIRLYGRPINVQYR | 71 | P57052 | |
| IVQLVQRYRSGIRGY | 1111 | O00763 | |
| VVQRRHYRIGLNLFN | 751 | Q5JU85 | |
| NGTERVRGVARYIYN | 51 | P05538 | |
| QHAAYRNQGLYRLGN | 266 | Q9HB15 | |
| QGYVRIRSRRLGIYQ | 11 | Q9P104 | |
| RITNIQRHQGGRYYC | 96 | Q7Z553 | |
| NNGIHYRLRLVYNNG | 106 | Q9BQW3 | |
| RNIDVYVHRVGYIGR | 546 | Q86TM3 | |
| ILYNYRHGGRQGQII | 476 | P06396 | |
| VVYNRQQHSQRLYLG | 711 | Q6ZMW3 | |
| KQHGQIRGYQVTYVR | 736 | P10586 | |
| HLQNGIIRGYQIGYR | 1011 | O60469 | |
| GVLQNMRVPYNRRHY | 166 | P48775 | |
| YGEQRGGRVFIYQRR | 486 | P20701 | |
| RYQGRAQAVLQQYQH | 201 | Q9UID3 | |
| VVRGGTLYYQRRQRH | 41 | O95625 | |
| RVYQNRDFRGHNRGY | 66 | Q9Y2W1 | |
| RQYRLIVHNGYCDGR | 181 | P02753 | |
| ALRHYINLITRQRYG | 51 | P01303 |